Eccrine syringofibroadenoma of clear cell variant: An immunohistochemical study

American Journal of Dermatopathology

Volumn 27, Issue 3, 2005, Pages 228-231

  Hu, Shasa ^a   Bakshandeh, Haleh ^a   Kerdel, Francisco A ^a,b   Rongioletti, Franco ^c   Romanelli, Paolo ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Cedars Medical Center Miami   (United States)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Clear cell; Differentiation; Eccrine syringofibroadenoma; Estrogen and progesterone receptors; Gross cystic disease fluid protein 15

Indexed keywords

CELL PROTEIN; ESTROGEN RECEPTOR; GLYCOGEN; KERATIN; PROGESTERONE RECEPTOR; PROTEIN GCDFP 15; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CLEAR CELL CARCINOMA; EPITHELIUM CELL; FEMALE; FIBROADENOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KNEE DISEASE; PAPULE; PRIORITY JOURNAL; PUNCH BIOPSY; SWEAT GLAND TUMOR; SYRINGOFIBROADENOMA; SYRINGOMA;

ADENOMA, SWEAT GLAND; CARRIER PROTEINS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLYCOPROTEINS; GRANULOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SWEAT GLAND NEOPLASMS;

EID: 19444362107     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.dad.0000158299.10169.1a     Document Type: Article

References (19)

1. Mascaro JM. Considerations sur les tumeurs fibroepitheliales: le syringofibradenome eccrine. Ann Dermatol Syphiligr (Paris). 1963;90: 143-153.
2. Starink TM. Eccrine syringofibroadenoma: multiple lesions representing a new cutaneous marker of the Schopf syndrome, and solitary nonhereditary tumors. J Am Acad Dermatol. 1997;36:569-576.
3. Rongioletti F, Gambini C, Parodi A, et al. Mossy leg with eccrine syringofibroadenomatous hyperplasia resembling multiple eccrine syringofibroadenoma. Clin Exp Dermatol. 1996;21:454-456.
4. Gambini C, Rongioletti F, Semino MT, et al. Solitary eccrine syringofibroadenoma (or eccrine syringofibroadenomatous hyperplasia?) and diabetic polyneuropathy. Dermatology. 1996;193:68-69.
5. Takeda H, Mitsuhashi Y, Hayashi M, et al. Eccrine syringofibroadenoma: case report and review of the literature. J Eur Acad Dermatol Venereol. 2000;15:147-149.
6. Komine M, Hattori N, Tamaki K. Eccrine syringofibroadenoma (Mascaro): an immunohistochemical study. Am J Dermatopathol. 2000; 22:171-175.
7. Fouilloux B, Perrin C, Dutoit M, et al. Clear cell syringofibroadenoma (of Mascaro) of the nail. Br J Dermatol. 2001;144:625-627.
8. Eckert F, Nilles M, Altmannsberger M. Eccrine syringofibroadenoma: a case report with analysis of cytokeratin expression. Br J Dermatol. 1992;126:257-261.
9. Ohnishi T, Suzuki T, Watanabe S. Eccrine syringofibroadenoma. Report of a case and immunohistochemical study of keratin expression. Br J Dermatol. 1995;133:449-454.
10. Ochonisky S, Wechsler J, Marinho E, et al. Eccrine syringofibroadenomatosis (Mascaro) with mucous involvement. Arch Dermatol. 1994;130: 933-934.
11. Kanitakis J, Zambruno G, Euvrard S, et al. Eccrine syringofibroadenoma. Immunohistological study of a new case. Am J Dermatopathol 1987;9: 37-40.
12. Sueki H, Miller SJ, Dzubow LM, et al. Eccrine syringofibroadenoma (Mascaro): an ultrastructural study. J Cutan Pathol. 1992;19:232-239.
13. Fretzin DF, Sloan JB, Beer K, et al. Eccrine syringofibroadenoma. A clear-cell variant. Am J Dermatopathol. 1995;17:591-593.
14. Timpanidis PC, Lakhani SR, Groves RW. Progesterone receptor-positive eruptive syringoma associated with diabetes. J Am Acad Dermatol. 2003; 48:S103-S104.
15. Van Leeuwen RL, Lavrijsen AP, Starink TM. Eccrine syringofibroadenoma: the simultaneous occurrence of two histopathological variants (conventional and clear-cell type) in one patient. Br J Dermatol. 1999; 141:947-949.
16. Mazoujian G, Pinkus GS, Davis S, et al. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol. 1983;110:105-112.
17. Saga K. Histochemical and immunohistochemical markers for human eccrine and apocrine sweat glands: an aid for histopathologic differentiation of sweat gland tumors. J Investig Dermatol Symp Proc. 2001;6:49-53.
18. Mazoujian G, Margolis R. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Am J Dermatopathol. 1988;10:28-35.
19. Ansai S, Koseki S, Hozumi Y, et al. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation. Am J Dermatopathol. 1995;17: 249-255.